1. Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients. Issue 6 (13th February 2018) Authors: Mösges, R.; Koch, A. F.; Raskopf, E.; Singh, J.; Shah‐Hosseini, K.; Astvatsatourov, A.; Hauswald, B.; Yarin, Y.; Corazza, F.; Haazen, L.; Pirotton, S.; Allekotte, S.; Zadoyan, G.; Legon, T.; Durham, S. R.; Shamji, M. H. Journal: Allergy Issue: Volume 73:Issue 6(2018) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗